- Home
- HUMA vs CYH Comparison
HUMA vs CYH Comparison
Compare HUMA & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- CYH
- Stock Information
- Founded
- HUMA 2004
- CYH 1985
- Country
- HUMA United States
- CYH United States
- Employees
- HUMA N/A
- CYH N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- CYH Hospital/Nursing Management
- Sector
- HUMA Health Care
- CYH Health Care
- Exchange
- HUMA Nasdaq
- CYH Nasdaq
- Market Cap
- HUMA 427.2M
- CYH 375.1M
- IPO Year
- HUMA N/A
- CYH 1991
- Fundamental
- Price
- HUMA $1.68
- CYH $2.41
- Analyst Decision
- HUMA Strong Buy
- CYH Hold
- Analyst Count
- HUMA 6
- CYH 8
- Target Price
- HUMA $14.60
- CYH $4.02
- AVG Volume (30 Days)
- HUMA 6.6M
- CYH 2.4M
- Earning Date
- HUMA 05-09-2025
- CYH 04-23-2025
- Dividend Yield
- HUMA N/A
- CYH N/A
- EPS Growth
- HUMA N/A
- CYH N/A
- EPS
- HUMA N/A
- CYH N/A
- Revenue
- HUMA N/A
- CYH $12,634,000,000.00
- Revenue This Year
- HUMA N/A
- CYH N/A
- Revenue Next Year
- HUMA $1,178.15
- CYH $4.16
- P/E Ratio
- HUMA N/A
- CYH N/A
- Revenue Growth
- HUMA N/A
- CYH 1.15
- 52 Week Low
- HUMA $1.15
- CYH $2.24
- 52 Week High
- HUMA $9.97
- CYH $6.29
- Technical
- Relative Strength Index (RSI)
- HUMA 38.93
- CYH 38.80
- Support Level
- HUMA $1.43
- CYH $2.33
- Resistance Level
- HUMA $1.62
- CYH $2.60
- Average True Range (ATR)
- HUMA 0.18
- CYH 0.19
- MACD
- HUMA 0.07
- CYH 0.01
- Stochastic Oscillator
- HUMA 70.67
- CYH 32.69
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.